Rozerem Takeda Pharmaceuticals North America, Inc. - Treatment for Insomnia
Rozerem is the first and only prescription sleep medication that has shown no evidence of abuse and dependence, and is therefore not designated as a controlled substance. Rozerem is indicated for the treatment of adults with insomnia characterized by difficulty with sleep onset, and can be prescribed for long-term use. Aczone (dapsone) Gel 5%Posted: July 2005
Related articles
- Takeda Submits New Drug Application for Ramelteon, an Investigational Sleep Drug - September 24, 2004
Rozerem (ramelteon) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
